CardiovascularORALGeneric
FLUVASTATIN SODIUM
FLUVASTATIN SODIUM
Standard Dose
80MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary
Approval overview FLUVASTATIN SODIUM is listed in Drugs@FDA under application 078872 (ANDA).
Marketing status: None (Tentative Approval) Active ingredient FLUVASTATIN SODIUM Form and strength TABLET, EXTENDED RELEASE; ORAL - 80MG Sponsor PAR PHARM Submission history Latest submission status date: 2009-09-15 00:00:00.
Structured Monograph
Clinical summary
Approval overview FLUVASTATIN SODIUM is listed in Drugs@FDA under application 078872 (ANDA). Marketing status: None (Tentative Approval) Active ingredient FLUVASTATIN SODIUM Form and strength TABLET, EXTENDED RELEASE; ORAL - 80MG Sponsor PAR PHARM Submission history Latest submission status date: 2009-09-15 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
Interaction Notes
- No interaction notes stored yet.